Table 1.
Demographics and clinical characteristics of participants.
| PD patients fallers (mean ± SD) | Older adults fallers (mean ± SD) | Older adults non-fallers (mean ± SD) | P | Post hoc (Mann Whitney) | |
|---|---|---|---|---|---|
| Age (years) | 72.6 ± 4.4 | 73.4 ± 4.2 | 72.1 ± 4.9 | >0.05 | – |
| Male/Female | 17/16 | 7/10 | 9/5 | >0.05 | |
| Education (years) | 9.8 ± 4.6 | 11.2 ± 4.4 | 10.8 ± 4.1 | >0.05 | – |
| UPDRS III (score) | 30.3 ± 9.13 | – | – | – | – |
| LEDD (mg) | 775.5 ± 358.6 | – | – | – | – |
| Falls in 6 months prior to study (number) | 3.8 ± 2.1 | 2.6 ± 1.0 | – | 0.031 | – |
| MoCA (score) | 23.7 ± 3.9 | 26.4 ± 1.6 | 28.3 ± 2.0 | <0.000 | §p = 0.006 |
| #p < 0.000 | |||||
| ∞p = 0.012 |
PD-F, Parkinson’s Disease fallers; OLD-F, Older adults fallers; OLD-NF, Older adults non fallers; UPDRS, Unified Parkinson’s Disease Rating Scale; LEDD, Levodopa Equivalent Daily Dose; MoCA, Montreal Cognitive Assessment; Post hoc: §PD-F vs. OLD-F; #PD-F vs. OLD-NF; ∞OLD-F vs. OLD-NF.